Branded Injectables to 2020: Analyzes therapeutic demand drivers and evaluates branded injectables in ten major therapeutic markets - 8NEWS - WRIC | News Where You Live

Branded Injectables to 2020: Analyzes therapeutic demand drivers and evaluates branded injectables in ten major therapeutic markets

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, May 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ns9q2p/branded) has announced the addition of the "Branded Injectables to 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Advances in coatings and device designs have led to prefilled biologicals in patient-friendly drug-device combination products that were not possible just a few years ago. Prefilled drug cartridges have reduced the cost of injectable pens and autoinjectors, making them accessible to a larger segment of the chronically ill.

Injectors with advanced features such as variable dosing, dose counters and audible cues are making self-administration safer for patients prescribed immune modulators with black box warnings. To streamline the drug-device development process, drug developers are increasingly aligning themselves with device suppliers, increasing the level of concurrent engineering, identifying design challenges earlier and minimizing possible delays that could result.

This trend represents risks for injectable drug firms competing for device solutions for their sophisticated formulations. It is also an opportunity for smaller device suppliers who are able to demonstrate the financial and technological resources to address the needs of injectable drug developers.

Highlights

  • Analyzes therapeutic demand drivers and evaluates branded injectables in ten major therapeutic markets
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Assess significant managed care, technology, and regulatory factors affecting branded injectable drug markets.
  • Provides market data and forecasts to 2020

Key Topics Covered:

1. Executive Summary

2. Anticoagulants

3. Antivirals

4. Autoimmune Diseases

5. Multiple Sclerosis

6. Diabetes

7. Hematopoietics

8. Hormone Replacement

9. Migraine

10. Osteoporosis

11. Reproductive Health

For more information visit http://www.researchandmarkets.com/research/ns9q2p/branded

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

301 Arboretum Place, Richmond
VA, 23236

Telephone: 804.330.8888
Fax: 804.330.8881
Email: news@wric.com

Can't find something?
Powered by WorldNow
All content © Copyright 2000 - 2014 Media General Communications Holdings, LLC. A Media General Company.